AML with germline DDX41 variants is a clinicopathologically distinct entity with an indolent clinical course and favorable outcome-Reference-Cited by-同舟云学术

AML with germline DDX41 variants is a clinicopathologically distinct entity with an indolent clinical course and favorable outcome

Published:2021-10-20 Issue: Volume: Page:
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Li Peng^ORCID,White Thomas,Xie Wei^ORCID,Cui Wei^ORCID,Peker Deniz,Zeng Gang^ORCID,Wang Huan-You,Vagher Jennie,Brown Sara^ORCID,Williams Margaret,Kovacsovics Tibor,Patel Jay L.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

https://www.nature.com/articles/s41375-021-01404-0.pdf

Reference36 articles.

1. Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391–405. https://doi.org/10.1182/blood-2016-03-643544.

2. Kennedy AL, Shimamura A. Genetic predisposition to MDS: clinical features and clonal evolution. Blood. 2019;133:1071–85. https://doi.org/10.1182/blood-2018-10-844662.

3. Rio-Machin A, Vulliamy T, Hug N, Walne A, Tawana K, Cardoso S, et al. The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants. Nat Commun. 2020;11:1044. https://doi.org/10.1038/s41467-020-14829-5.

4. Sebert M, Passet M, Raimbault A, Rahme R, Raffoux E, Sicre de Fontbrune F, et al. Germline DDX41 mutations define a significant entity within adult MDS/AML patients. Blood. 2019;134:1441–4. https://doi.org/10.1182/blood.2019000909.

5. Tawana K, Drazer MW, Churpek JE. Universal genetic testing for inherited susceptibility in children and adults with myelodysplastic syndrome and acute myeloid leukemia: are we there yet? Leukemia. 2018;32:1482–92. https://doi.org/10.1038/s41375-018-0051-y.

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multifunctional role of DEAD-box helicase 41 in innate immunity, hematopoiesis and disease;Frontiers in Immunology;2024-08-09

2. How to manage patients with germline DDX41 variants: Recommendations from the Nordic working group on germline predisposition for myeloid neoplasms;HemaSphere;2024-08

3. Peripheral Blood and Bone Marrow Findings in Treatment-Naive Patients With Cytopenia(s)/Myeloid Neoplasms Harboring Both a Germline and a Somatic DDX41 Mutation;Applied Immunohistochemistry & Molecular Morphology;2024-07-24

4. Updates on germline predisposition in pediatric hematologic malignancies: What is the role of flow cytometry?;Cytometry Part B: Clinical Cytometry;2024-06-28

5. Rapid growth of acquired UBA1 mutations predisposes male patients to low-risk MDS;2024-05-23